The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer

Urologic Clinics of North America

Volumn 23, Issue 4, 1996, Pages 531-540

  Partin, A W ^a   Carter, H B ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; CANCER DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0030481790     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70333-5     Document Type: Article

References (63)

1. G.L. Andriole W.J. Catalona Using PSA to screen for prostate cancer. The Washington University Experience Urol Clin North Am 20 1993 647
2. R.J. Babaian H. Miyashita R.B. Evans Early detection program for prostate cancer: Results and identification of high-risk patient population Urology 37 1991 193
3. M.C. Benson I.S. Whang C.A. Olsson Use of prostate specific antigen density to enhance predictive value of intermediate levels of serum prostate specific antigen J Urol 147 1992 817 821
4. M.C. Benson I.S. Whang A. Pantuck Prostate specific antigen density: Means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815 816
5. 1-antichymotrypsin by PSA-containing cells of human prostate epithelium Urology 42 1993 502 509
6. T. Bjork P.A. Abrahamsson H. Lilja Rates of clearance of free and complexed forms of PSA in serum after radical prostatectomy and transurethral microwave therapy [abstract] J Urol 153 1995 295A
7. M.K. Brawer J. Beatie M.H. Wener Screening for prostate carcinoma with prostate-specific antigen: Results of the second year J Urol 150 1993 106
8. M.K. Brawer M.P. Chetner J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 1992 841 845
9. Canadian Task Force on the Periodic Health Examination Periodic health examination, 1991 update, 3: Secondary prevention of prostate cancer Can Med Assoc J 145 1991 413 428
10. H.B. Carter J.D. Pearson J.E. Metter Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease JAMA 267 1992 2215 2220
11. W.J. Catalona Screening for prostate cancer: Enthusiasm Urology 42 1993 113
12. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
13. W.J. Catalona D.S. Smith T.L. Ratliff J.W. Basler Detection of organ-confined prostate cancer is increased through prostate-specific antigen based screening JAMA 270 1993 948 954
14. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
15. W.J. Catalona D.S. Smith R.L. Wolfert Evaluation of percentage of free serum PSA to improve specificity of prostate cancer screening JAMA 274 1995 1214 1220
16. 1-antichymotrypsin: Potential reference material for international standardization of PSA immunoassays Clin Chem 41 1995 1273 1282
17. G.W. Chodak H.W. Schoenberg Early detection of prostate cancer by routine screening JAMA 252 1984 3261
18. 1-antichymotrypsin as an indicator of prostate cancer J Urol 150 1993 100 105
19. A. Christensson C.B. Laurell H. Lilja Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors Eur J Biochem 194 1990 755 763
20. A. Christensson H. Lilja Complex formation between protein C inhibitor and prostate-specific antigen in-vitro and in human semen Eur J Biochem 220 1994 45 53
21. W.H. Cooner Definition of the ideal tumor marker Urol Clin North Am 20 1993 575
22. W.H. Cooner B.R. Mosley Rutherford C.L. Jr Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 143 1990 1146 1154
23. E.D. Crawford E.P. DeAntonio PSA as a screening test for prostate cancer Urol Clin North Am 20 1993 637
24. W.J. Ellis M.P. Chetner S.D. Preston M.K. Brawer Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography J Urol 52 1994 1520 1525
25. J.W. Feightner The early detection and treatment of prostate cancer: The perspective of the Canadian Task Force on the Periodic Health Examination J Urol 152 1994 1682 1684
26. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289 294
27. P. Hammerer H. Huland Systematic sextant biopsies in 651 patients referred for prostate evaluation J Urol 151 1994 99 102
28. 1-antichymotrypsin Prostate 27 1995 166 175
29. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate-specific antigen in patients with prostate cancer J Urol 142 1989 1011 1017
30. F. Labrie A. Dupont R. Suburu Serum prostate specific antigen as pre-screening test for prostate cancer J Urol 147 1992 846 852
31. M. Laurell A. Christensson P.A. Abrahamsson Protein C inhibitor in human body fluids, seminal plasma is rich in inhibitor antigen deriving cells throughout the male reproductive system J Clin Invest 89 1992 1094 1101
32. 1-antichymotrypsin Urol Clin North Am 20 1993 681 686
33. 1-antichymotrypsin Clin Chem 37 1991 1618 1625
34. 1-antichymotrypsin in blood: Implications for procedures to measure PSA in serum Cancer 70 1992 230 234
35. P.J. Littrup R.A. Kane C.J. Mettlin Cost-effective prostate cancer detection Cancer 74 1994 3146 3158
36. M.S. Litwin deKernion J.B. Editorial: Perspectives on the problem of prostate cancer J Urol 152 1994 1680 1681
37. A.A. Luderer Chen Y.-T. T.F. Soriano Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology 146 1995 187 194
38. 1-antichymotrypsin Klapdor R. Tumor Associated Antigens. Oncogenes, Receptors, Cytokines in Tumor Diagnosis and Therapy at the beginning of the nineties 1992 Munchen, W. Zuchschwerdt Verlag 321 327
39. R.T. McCormack H.G. Rittenhouse J.A. Finlay Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era Urology 45 1995 729 744
40. C. Mettlin G. Jones H. Averette Defining and updating the American Cancer Society guidelines for the cancer-related checkup: Prostate and endometrial cancers CA Cancer J Clin 43 1993 42
41. C. Mettlin F. Lee J. Drago The American Cancer Society National Prostate Cancer Detection Project Cancer 67 1991 2949
42. J.E. Oesterling D.W. Chan J.I. Epstein Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J Urol 139 1988 766 772
43. J.E. Oesterling S.J. Jacobsen C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges JAMA 270 1993 860 864
44. J.E. Oesterling S.J. Jacobsen G.G. Klee Free, complexed and total serum PSA: The establishment of appropriate reference ranges for their concentrations and ratios J Urol 154 1995 1090 1095
45. J.E. Oesterling H. Lilja Early detection and diagnosis N.J. Vogelzang P.T. Scardino W.U. Shipley Coffey D.S. Comprehensive Textbook of Genitourinary Oncology 1995 Williams and Wilkens Baltimore 668 673
46. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747 752
47. A.W. Partin W.J. Catalona P.C. Southwick Analysis of percent free PSA for prostate cancer detection: Influence of total PSA, prostate volume, and age Urology 1996 in press
48. A.W. Partin J.E. Oesterling The clinical usefulness of prostate specific antigen: Update 1994 J Urol 152 1994 1358 1368
49. A.W. Partin J. Yoo H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer J Urol 150 1993 110 114
50. C.S. Powell A.M. Fielding K. Rosser Prostate-specific antigen: A screening test for prostate cancer Br J Urol 64 1989 504
51. A.F. Prestigiacamo T.A. Stamey Clinical usefulness of free and complexed PSA Scand J Clin Lab Invest Suppl 221 1995 32 34
52. D.S. Smith W.J. Catalona Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection J Urol 152 1994 1163 1167
53. R.L. Sokoloff J.A. Esgate T.J. Wang Effect of prostate-specific antigen forms on PSA quantitation [abstract] J Urol 151 1994 450A
54. 1-antichymotrypsin: Influence of cancer volume, location and therapeutic selection of resistant clones J Urol 152 1994 1510 1514
55. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
56. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer. Assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222
57. 1-antichymotrypsin before diagnosis of prostate cancer Lancet 344 1994 1594 1598
58. N.N. Stone E.P. DeAntoni E.D. Crawford Screening for prostate cancer by digital rectal examination and prostate-specific antigen: Results of prostate cancer awareness week, 1989–1992 Urology 44 1994 18 25
59. US Preventive Services Task Force Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions 1993 Williams and Wilkins Baltimore 63
60. P.C. Walsh Using prostate-specific antigen to diagnose prostate cancer: Sailing in uncharted waters Ann Intern Med 119 1993 948
61. T.J. Wang T. Hill K. Norton Specific immunoassay for free PSA and its clinical relevance [abstract] J Urol 153 1995 295A
62. 1-antichymotrypsin complexes in serum Eur J Clin Chem Clin Biochem 29 1991 787
63. A.M. Zhou P.U. Tewari B.I. Bluestein Multiple forms of PSA in serum: Differences in immunorecognition by monoclonal and ployclonal assays Clin Chem 39 1993 2483 2491